2H-naphth[2,3-b]-1,4-oxazine derivatives, their preparation and their use as serotonin 1D (5-HT10) receptor agonists
申请人:SANDOZ LTD.
公开号:EP0641787A1
公开(公告)日:1995-03-08
Compounds of formula I
wherein
R₁is (C1-4)alkyl, (C3-6)alkenyl, whereby the double bond is not in α-position to the nitrogen atom, or (C3-7)cycloalkyl(C1-2)alkyl,
R₂is (C1-4)alkoxy, (C2-6)alkenyloxy or (C3-7)cycloalkyl(C1-2)alkoxy, and
R₃is (C1-4)alkylcarbonyl, (C1-4)alkyl, α-hydroxy(C1-4)alkyl, (C2-5)alkenyl, (C1-4)alkoxy(C1-4)alkyl or (C3-7)cycloalkyl,
in free base or acid addition salt form, exhibit serotonin 1D (5-HT₁D)-receptor agonistic activity and are thus useful interalia in the treatment of migraine, depression, anxiety and pain.
式I的化合物,其中R₁为(C1-4)烷基,(C3-6)烯基,其双键不在氮原子的α位,或(C3-7)环烷基(C1-2)烷基,R₂为(C1-4)烷氧基,(C2-6)烯氧基或(C3-7)环烷基(C1-2)烷氧基,R₃为(C1-4)烷基酰基,(C1-4)烷基,α-羟基(C1-4)烷基,(C2-5)烯基,(C1-4)烷氧基(C1-4)烷基或(C3-7)环烷基,以自由碱或酸盐形式存在,表现出5-羟色胺1D(5-HT₁D)受体激动活性,因此在治疗偏头痛、抑郁症、焦虑和疼痛等方面有用。